The Fort Worth Press - Moderna to Present at Upcoming Conferences in June 2025

USD -
AED 3.672504
AFN 65.000368
ALL 81.652501
AMD 376.168126
ANG 1.79008
AOA 917.000367
ARS 1431.790402
AUD 1.425923
AWG 1.8025
AZN 1.70397
BAM 1.654023
BBD 2.008288
BDT 121.941731
BGN 1.67937
BHD 0.375914
BIF 2954.881813
BMD 1
BND 1.269737
BOB 6.889932
BRL 5.217404
BSD 0.997082
BTN 90.316715
BWP 13.200558
BYN 2.864561
BYR 19600
BZD 2.005328
CAD 1.36855
CDF 2200.000362
CHF 0.77566
CLF 0.021803
CLP 860.890396
CNY 6.93895
CNH 6.929815
COP 3699.522179
CRC 494.312656
CUC 1
CUP 26.5
CVE 93.2513
CZK 20.504104
DJF 177.555076
DKK 6.322204
DOP 62.928665
DZD 129.553047
EGP 46.73094
ERN 15
ETB 155.0074
EUR 0.846204
FJD 2.209504
FKP 0.73461
GBP 0.734457
GEL 2.69504
GGP 0.73461
GHS 10.957757
GIP 0.73461
GMD 73.000355
GNF 8752.167111
GTQ 7.647681
GYD 208.609244
HKD 7.81385
HNL 26.338534
HRK 6.376104
HTG 130.618631
HUF 319.703831
IDR 16855.5
ILS 3.110675
IMP 0.73461
INR 90.57645
IQD 1306.186308
IRR 42125.000158
ISK 122.710386
JEP 0.73461
JMD 156.057339
JOD 0.70904
JPY 157.200504
KES 128.622775
KGS 87.450384
KHR 4023.848789
KMF 419.00035
KPW 899.990005
KRW 1463.803789
KWD 0.30721
KYD 0.830902
KZT 493.331642
LAK 21426.698803
LBP 89293.839063
LKR 308.47816
LRD 187.449786
LSL 16.086092
LTL 2.95274
LVL 0.60489
LYD 6.314009
MAD 9.153622
MDL 17.000296
MGA 4426.402808
MKD 52.129054
MMK 2099.624884
MNT 3567.867665
MOP 8.023933
MRU 39.425769
MUR 46.060378
MVR 15.450378
MWK 1728.952598
MXN 17.263604
MYR 3.947504
MZN 63.750377
NAD 16.086092
NGN 1366.980377
NIO 36.694998
NOK 9.690604
NPR 144.506744
NZD 1.674621
OMR 0.383441
PAB 0.997082
PEN 3.354899
PGK 4.275868
PHP 58.511038
PKR 278.812127
PLN 3.56949
PYG 6588.016407
QAR 3.634319
RON 4.310404
RSD 99.268468
RUB 76.789716
RWF 1455.283522
SAR 3.748738
SBD 8.058149
SCR 13.84955
SDG 601.503676
SEK 9.023204
SGD 1.272904
SHP 0.750259
SLE 24.450371
SLL 20969.499267
SOS 568.818978
SRD 37.818038
STD 20697.981008
STN 20.719692
SVC 8.724259
SYP 11059.574895
SZL 16.08271
THB 31.535038
TJS 9.342721
TMT 3.505
TND 2.891792
TOP 2.40776
TRY 43.612504
TTD 6.752083
TWD 31.590367
TZS 2577.445135
UAH 42.828111
UGX 3547.71872
UYU 38.538627
UZS 12244.069517
VES 377.985125
VND 25950
VUV 119.182831
WST 2.73071
XAF 554.743964
XAG 0.012866
XAU 0.000202
XCD 2.70255
XCG 1.797032
XDR 0.689923
XOF 554.743964
XPF 100.858387
YER 238.403589
ZAR 16.04457
ZMK 9001.203584
ZMW 18.570764
ZWL 321.999592
  • SCS

    0.0200

    16.14

    +0.12%

  • RBGPF

    0.1000

    82.5

    +0.12%

  • CMSD

    0.0600

    23.95

    +0.25%

  • NGG

    1.1700

    88.06

    +1.33%

  • GSK

    1.0600

    60.23

    +1.76%

  • BCC

    1.8700

    91.03

    +2.05%

  • CMSC

    -0.0400

    23.51

    -0.17%

  • RIO

    2.2900

    93.41

    +2.45%

  • BCE

    -0.4900

    25.08

    -1.95%

  • RELX

    -0.7100

    29.38

    -2.42%

  • AZN

    5.8700

    193.03

    +3.04%

  • JRI

    0.0900

    12.97

    +0.69%

  • RYCEF

    0.2600

    16.88

    +1.54%

  • BTI

    0.8400

    62.8

    +1.34%

  • VOD

    0.4900

    15.11

    +3.24%

  • BP

    0.8400

    39.01

    +2.15%

Moderna to Present at Upcoming Conferences in June 2025
Moderna to Present at Upcoming Conferences in June 2025

Moderna to Present at Upcoming Conferences in June 2025

CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:

Text size:

Jefferies Global Health Care Conference, on Thursday, June 5th at 10:30am ET

Goldman Sachs 46th Annual Global Healthcare Conference, on Wednesday, June 11th at 8:40am ET

A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website.

investors.modernatx.com.

A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]

SOURCE: Moderna, Inc.



View the original press release on ACCESS Newswire

A.Nunez--TFWP